Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Organ Type & End-users The global organ preservation market will witness a robust CAGR of 6.93%, valued at $206.89 million in 2021, expected to appreciate and reach $377.97 million by 2030, confirms Strategic Market Research. Organ preservation may be defined as storing a donated organ in specially prepared conditions that can be taken out when organ transplantation needs to be performed. The Organ Preservation industry currently works on intraabdominal organs and intrathoracic organs. Specially prepared organ preservation fluids are required to preserve organs, such as the University of Wisconsin (UW) organ preservation solution, Custodial HTK solution, and Allopurinol. The liver, pancreas, spleen, kidneys, adrenal glands, heart, lung, kidneys, stomach and intestines, thymus, skin, brain, eyes, thyroid, and joints can be preserved and used for an organ transplant. Organ preservation is becoming more important due to the rising organ demand and the increased waiting time for patients for transplantation. According to the US Health Resources and Services Administration, more than 100,000 patients are waiting for an organ transplant in the US, and 17 people will die each day waiting for an organ transplant in 2021. Advances in organ preservation can lower the cost of transplantation and the expenditures associated with treating post-transplant problems. Organ preservation reduces costs in procurement, transportation, and post-transplant care. Key Industry Drivers - Growing Geriatric Population, Growth in cases of Multiple Organ Failure As the geriatric population grows, the number of older individuals receiving organ transplants has risen greatly. According to the US Health Resources and Services Administration, more than 7000 organ transplants were performed on patients aged 65 and older. According to the UN World Population Ageing Report, there were 728 million people aged 65 and older in 2021. The increasing geriatric population can help shift the industry trends and help it to propel further at a rapid pace. The growing cases of multiple organ failure have also helped drive market growth. Sepsis is one of the main causes of multiple organ failure. According to an NCBI study, 22% of patients suffered from sepsis. 56% of these patients died from multiple organ failure due to sepsis. Multiple organ failure causes the demand for organ donation to rise among patients, which increases the global organ preservation market growth. Restraints - High Cost of Organ Transplantation The higher cost of organ transplantation causes its demand to decrease, hindering the market growth. According to a study, the average amount charged for a heart transplant in the USA in 2020 is USD 1,664,800, an intestine transplant is USD 1,240,700, and a bone marrow transplant is USD 1,071,700. The high organ transplantation costs force patients to seek alternative treatment methods. Opportunities - Newer Applications, Growing Healthcare Investments The increasing number of applications for organ transplants helps drive the market forward. Organ preservation in rectal cancer, organ preservation in rectal adenocarcinoma, organ preservation in head and neck cancer, allopurinol organ preservation, organ preservation by vitrification, newer organ preservation techniques, organ preservation for transplantation, organ preservation surgery for laryngeal cancer, organ preservation for hypopharyngeal cancer, organ preservation in oncology, organ preservation in laryngectomy, organ preservation methods in renal transplantation, normothermic organ preservation, organ preservation of oropharynx, organ preservation for pancreas transplantation, and organ preservation to cure penile cancer use new methods such as organ preservation perfusion and substances like UW organ preservation solution, HTK organ preservation solution, organ preservation polymers, and IGL-1 organ preservation solution. These organ preservation applications are necessary to combat the rising frequency of diseases. According to a study, 2000 to 4000 people in the United States of America will be diagnosed with hypopharyngeal cancer. Around 84,000 people worldwide were diagnosed with this disease, and around 39,000 people died of hypopharyngeal cancer in 2020. The growing healthcare investments by various governmental organizations can help increase organ preservation solutions market size. For example, CMS stated that the national healthcare expenditure rose by 9.7% to USD 4.1 trillion in 2020, or an average of about USD 12,500 per person in the United States of America, while CIHI stated that the total healthcare spending in Canada is more than CAD 308 billion in 2021 or CAD 8019 per person. The upgraded healthcare services will bring in more patients and donors, which can help boost the market growth. Market Analysis Of Different Segments Covered in the Report Based on Solution Custodial HTK University of Wisconsin Perfadex Others Based on Organ Type Heart Kidneys Lung Liver Others Based on Preservation Technique Static Cold Storage Normothermic Machine Perfusion Hypothermic Machine Perfusion Others Based on End-User Organ Transplant Centers Hospitals Specialty Clinics Regional Coverage Analysis North America United States of America Canada Europe Germany United Kingdom Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Mexico South Africa Saudi Arabia Brazil Rest of LAMEA Segments Analysis & Insights Based on the solution, the University of Wisconsin (UW) solution held the maximum industry share with 48.08%. The solution was one of the first intracellular organ preservation mediums. Its surge is attributed to metabolically inert substrates, such as raffinose and lactobionate, which enable improved physiological function, less histological damage, and better transportation outcomes of organs. The University of Wisconsin solution contains 17.83 g/l of raffinose pentahydrate and 35.83 g/l of lactobionic acid, ideal for flushing and cold storage of liver, kidney, and pancreas from the donor. The static cold storage segment had the largest global industry size based on preservation techniques, with 44.44% in 2019. The wide use of static cold storage for different organs and many companies offering this service helps drive market growth. Based on organs, the kidneys held the largest global organ preservation market share, with 40.28%. The increasing number of kidney failures and number of kidney transplants worldwide has fuelled the growth of this segment. According to different studies, around 25,000 kidney transplants were performed in the United States of America in 2021, compared to around 22,000 kidney transplants in 2018, a 13.6% average increase in 3 years. The heart segment is expected to grow at the quickest CAGR over the projection period. The increasing demand for hearts and the number of heart transplants have driven the industry segment’s growth. According to different studies, around 3800 heart transplants were performed in the United States of America in 2021, compared to around 3400 heart transplants in 2019, an 11.76% increase in 2 years. North America has the highest industry share with 42.61% of total revenue. The growing demand for organs and their adoption due to the rising number of chronic diseases like end-stage diseases has propelled the growth of this industry. According to the US Health Resources and Services Administration, more than 90,000 kidneys and 11,000 livers were in demand in the USA, while only around 24,000 kidney transplants and 9000 liver transplants were performed in 2020. Asia-Pacific is expected to develop the fastest throughout the projected period, owing to rising healthcare spending, more patient awareness, and increased demand for organ transplantation operations. Furthermore, the expanding aging population, rising kidney and heart failure prevalence, and rising healthcare spending are expected to fuel industry expansion in the upcoming years. According to the DGHS (Directorate General of Health Services), Ministry of Health and Family Welfare, Government of India, around 180,000 Indians suffer from renal failure every year, but only 6000 kidney transplants are performed each year. The ever-increasing need to meet the demand for organ donations in these countries accelerates the organ preservation solutions market growth. Organ Preservation Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 206.89 million The revenue forecast in 2030 USD 377.97 million Growth rate CAGR of approximately 6.93% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Million, CAGR (2021 - 2030) Segmentation By Solution, Organ Type, Preservation Technique, and Region. By Solution Custodial HTK, University of Wisconsin, Perfadex, Others By Organ Type Kidneys, Heart, Lung, Liver, Others By Route Of Administration Hypothermic Machine Perfusion, Static Cold Storage, Normothermic Machine Perfusion, & Others By Region Asia-Pacific, North America, Europe, LAMEA Country Scope United States of America, China, India, United Kingdom, Germany, Canada, Japan, Mexico, Brazil, Saudi Arabia, South Africa Company Usability Profiles XVIVO Perfusion AB, Essential Pharmaceuticals, LLC, TransMedics, Shanghai Genext Medical Technology, Bridge to Life Limited, Paragonix Technologies, 21st Century Medicine, Dr. Franz Köhler Chemie GmbH Carnamedica, Institut Georges Lopez, Global Transplant Solutions, Organ Preservation Solutions, SALF, Biochefa, Vascular Perfusion Solutions, Transplant Biomedicals, EBERS, SALF, Vascular Perfusion Solutions, TX Innovations, Preservation Solutions, EBERS, OrganOx Limited, Waters Medical Systems, Avionord, Biochefa. Global Organ Preservation Market Competitive Landscape Analysis The major competitors adopt strategies like mergers & acquisitions, partnerships, collaborations, and product launches to strengthen their position. The main competitors in the industry are: Paragonix Technologies TransMedics Dr. Franz Köhler Chemie GmbH Essential Pharmaceuticals, LLC XVIVO Perfusion AB Bridge To Life Limited 21st Century Medicine Shanghai Genext Medical Technology OrganOx Limited Carnamedica Preservation Solutions Waters Medical Systems Transplant Biomedicals Avionord Biochefa Institut Georges Lopez Organ Preservation Solutions TX Innovations SALF. Global Transplant Solutions Vascular Perfusion Solutions EBERS Recent Developments In March 2022, XVIVO announced EU MDR certification for its Kidney Assist Transport system. XVIVO believes that the certification will allow more patients to access kidneys donated through the transport system. In February 2022, Paragonix Technologies’ LUNGguard and SherpaPak® Cardiac Transport System were used in record cross-country donor organ transport cases. The lung was transported from Alaska to North Carolina, while the heart was transported from Alaska to Washington State, over a combined period of 31 hours and in 5 flights. Four transplant centers worked together to make these huge transfers happen. In December 2021, OrganOx announced the FDA’s pre-market approval (PMA) for its metra system. OrganOx believes that this approval will help them expand markets and reduce waitlist mortality. In July 2021, Institut Georges Lopez announced the building of a manufacturing faculty in Cheyyar, Tamil Nadu, India, for organ preservation. The company believes that manufacturing storage devices and solutions will begin soon, allowing more patients access to donated organs. In July 2021, TransMedics Group, Inc. announced the FDA 510 (k) clearance for its OCS Lung Solution. TransMedics believes that they demonstrate their commitment to supplying world-class organ preservation products to meet different patient needs with this clearance. Various Organ Preservation Products that Key Market Leaders Develop: Product Function Key Player ECOSOL Preservation of organs by persufflation, perfusion, and cold storage. TX Innovations VPS Encore Extension of the viability of organs beyond the current standard of care. Vascular Perfusion Solutions ARK Kidney Ex-vivo normothermic organ preservation of renal grafts. EBERS LS-T Enhanced organ preservation solution for heart and lung preservation. Organ Preservation Solutions WAVES Pulsatile hypothermic machine perfusion of donor’s kidneys. Institut Georges Lopez Frequently Asked Question About This Report How big is the organ preservation market? The global organ preservation market size was $206.89 Mn in 2021 and is predicted to reach $378.14 Mn by 2030. What is the organ preservation solutions market growth? The global organ preservation solutions market is expected to grow at a compound annual growth rate (CAGR) of 6.93% from 2021 to 2030 to reach USD 378.14 million by 2030. Which region is expected to lead the Market? North America is expected to lead the market, with 42.61% of total market revenue. Where are organs preserved? Organs are preserved in devices that employ static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and other techniques. What are the solutions for organ preservation? The University of Wisconsin, Custodial HTK, Perfadex, and other solutions can be used for organ preservation. What organ is in the highest demand for organ transplants? The kidneys are in the highest demand for organ transplants. Sources https://www.pennmedicine.org/updates/blogs/transplant-update/2022/march/6-quick-facts-about-organ-donation https://www.un.org/en/global-issues/ageing https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538252/ https://www.statista.com/statistics/808471/organ-transplantation-costs-us/ https://optn.transplant.hrsa.gov/news/all-time-records-again-set-in-2021-for-organ-transplants-organ-donation-from-deceased-donors/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Organ Preservation Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Organ Preservation Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By Solution Business Analysis 4.4.1 market, By Solution, 2021-2030 (USD Million) 4.5 By Organ Business Analysis 4.5.1 market, By Organ, 2021-2030 (USD Million) 4.6 Preservation Technique Business Analysis 4.6.1 market, By Preservation Technique, 2021-2030 (USD Million) 4.6 End-user Business Analysis 4.6.1 market, By End-user, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-user Analysis 5.11.1. Trends in End-user (2014-2020) 5.11.2. Trends in End-user (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Solution 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Solution Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. University of Wisconsin 7.3.1. University of Wisconsin market, 2021-2030 (USD Million) 7.4. Custodial HTK 7.4.1. Custodial HTK market, 2021-2030 (USD Million) 7.5. Perfadex 7.5.1. Perfadex market, 2021-2030 (USD Million) 7.6. Others 7.6.1. Others market, 2021-2030 (USD Million) 8. Market: By Organ Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Kidneys 8.3.1. Kidneys market, 2021-2030 (USD Million) 8.4. Heart 8.4.1. Heart market, 2021-2030 (USD Million) 8.5. Lung 8.5.1. Lung market, 2021-2030 (USD Million) 8.6. Liver 8.6.1. Liver market, 2021-2030 (USD Million) 8.7. Others 8.7.1. Others market, 2021-2030 (USD Million) 9. Market: By Preservation Technique Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Static Cold Storage 9.3.1. Static Cold Storage market, 2021-2030 (USD Million) 9.4. Hypothermic Machine Perfusion 9.4.1. Hypothermic Machine Perfusion market, 2021-2030 (USD Million) 9.5. Normothermic Machine Perfusion 9.5.1. Normothermic Machine Perfusion market, 2021-2030 (USD Million) 9.6. Others 9.6.1. Others market, 2021-2030 (USD Million) 10. Market: By End-user Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Organ Transplant Centers 10.3.1. Organ Transplant Centers market, 2021-2030 (USD Million) 10.4. Hospitals 10.4.1. Hospitals market, 2021-2030 (USD Million) 10.5. Specialty Clinics 10.5.1. Specialty Clinics market, 2021-2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, By Solution, 2021-2030 (USD Million) 11.1.2. North America market, By Organ, 2021-2030 (USD Million) 11.1.3. North America market, by End-user, 2021-2030 (USD Million) 11.1.4. North America market, by Country, 2021-2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By Solution, 2021-2030 (USD Million) 11.1.4.1.2. U.S. market, By Organ, 2021-2030 (USD Million) 11.1.4.1.3. U.S. market, by End-user, 2021-2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By Solution, 2021-2030 (USD Million) 11.1.4.2.2. Canada market, By Organ, 2021-2030 (USD Million) 11.1.4.2.3. Canada market, by End-user, 2021-2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By Solution, 2021-2030 (USD Million) 11.2.2. Europe market, By Organ, 2021-2030 (USD Million) 11.2.3. Europe market, by End-user, 2021-2030 (USD Million) 11.2.4. Europe market, by country, 2021-2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By Solution, 2021-2030 (USD Million) 11.2.4.1.2. U.K. market, By Organ, 2021-2030 (USD Million) 11.2.4.1.3. U.K. market, by End-user, 2021-2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By Solution, 2021-2030 (USD Million) 11.2.4.2.2. Germany market, By Organ, 2021-2030 (USD Million) 11.2.4.2.3. Germany market, by End-user, 2021-2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By Solution, 2021-2030 (USD Million) 11.2.4.3.2. France market, By Organ, 2021-2030 (USD Million) 11.2.4.3.3. France market, by End-user, 2021-2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By Solution, 2021-2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Organ, 2021-2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by End-user, 2021-2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By Solution, 2021-2030 (USD Million) 11.3.2. Asia Pacific market, By Organ, 2021-2030 (USD Million) 11.3.3. Asia Pacific market, by End-user, 2021-2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By Solution, 2021-2030 (USD Million) 11.3.4.1.2. China market, By Organ, 2021-2030 (USD Million) 11.3.4.1.3. China market, by End-user, 2021-2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By Solution, 2021-2030 (USD Million) 11.3.4.2.2. India market, By Organ, 2021-2030 (USD Million) 11.3.4.2.3. India market, by End-user, 2021-2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By Solution, 2021-2030 (USD Million) 11.3.4.3.2. Japan market, By Organ, 2021-2030 (USD Million) 11.3.4.3.3. Japan market, by End-user, 2021-2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By Solution, 2021-2030 (USD Million) 11.3.4.4.2. South Korea market, By Organ, 2021-2030 (USD Million) 11.3.4.4.3. South Korea market, by End-user, 2021-2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By Solution, 2021-2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Organ, 2021-2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by End-user, 2021-2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By Solution, 2021-2030 (USD Million) 11.4.2. Latin America market, By Organ, 2021-2030 (USD Million) 11.4.3. Latin America market, by End-user, 2021-2030 (USD Million) 11.4.4. Latin America market, by country, 2021-2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By Solution, 2021-2030 (USD Million) 11.4.4.1.2. Brazil market, By Organ, 2021-2030 (USD Million) 11.4.4.1.3. Brazil market, by End-user, 2021-2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By Solution, 2021-2030 (USD Million) 11.4.4.2.2. Mexico market, By Organ, 2021-2030 (USD Million) 11.4.4.2.3. Mexico market, by End-user, 2021-2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America market, By Solution, 2021-2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Organ, 2021-2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by End-user, 2021-2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By Solution, 2021-2030 (USD Million) 11.5.2. MEA market, By Organ, 2021-2030 (USD Million) 11.5.3. MEA market, by End-user, 2021-2030 (USD Million) 11.5.4. MEA market, by Region, 2021-2030 (USD Million) 12. Competitive Landscape 12.1 Paragonix Technologies 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Solution Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. XVIVO Perfusion AB 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Solution Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Dr. Franz Köhler Chemie GmbH 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Solution Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Essential Pharmaceuticals, LLC 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Solution Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. TransMedics 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Solution Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. OrganOx Limited 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Solution Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. 21st Century Medicine 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Solution Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Shanghai Genext Medical Technology 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Solution Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Bridge to Life Limited 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Solution Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Waters Medical Systems 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Solution Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Preservation Solutions 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Solution Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Carnamedica 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Solution Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Transplant Biomedicals 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Solution Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. Institut Georges Lopez 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Solution Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Global Transplant Solutions 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Solution Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. Avionord 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. Solution Portfolio Analysis 12.16.4. Business Strategy & Recent Development 12.17. Organ Preservation Solutions 12.17.1. Company overview 12.17.2. Financial performance 12.17.3. Solution Portfolio Analysis 12.17.4. Business Strategy & Recent Development 12.18. EBERS 12.18.1. Company overview 12.18.2. Financial performance 12.18.3. Solution Portfolio Analysis 12.18.4. Business Strategy & Recent Development 12.19. SALF 12.19.1. Company overview 12.19.2. Financial performance 12.19.3. Solution Portfolio Analysis 12.19.4. Business Strategy & Recent Development 12.20. Biochefa 12.20.1. Company overview 12.20.2. Financial performance 12.20.3. Solution Portfolio Analysis 12.20.4. Business Strategy & Recent Development 12.21. Vascular Perfusion Solutions 12.21.1. Company overview 12.21.2. Financial performance 12.21.3. Solution Portfolio Analysis 12.21.4. Business Strategy & Recent Development 12.22. TX Innovations 12.22.1. Company overview 12.22.2. Financial performance 12.22.3. Solution Portfolio Analysis 12.22.4. Business Strategy & Recent Development List of Tables (81 Tables) TABLE 1. MARKET, By Solution, 2021-2030 (USD Million) TABLE 2. MARKET FOR University of Wisconsin, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Custodial HTK, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Perfadex, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET, By Organ, 2021-2030 (USD Million) TABLE 7. MARKET FOR Kidneys, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Heart, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Lung, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR Liver, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 13. MARKET FOR Organ Transplant Centers, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Specialty Clinics, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET, BY Preservation Technique, 2021-2030 (USD Million) TABLE 17. MARKET FOR Static Cold Storage, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET FOR Hypothermic Machine Perfusion, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR Normothermic Machine Perfusion, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, By Solution, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By Organ, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, By Solution, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By Organ, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. ASIA-PACIFIC MARKET, By Solution, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, By Organ, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 35. LAMEA MARKET, By Solution, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, By Preservation Technique, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY END-USER, 2021-2030 (USD Million) TABLE 38. Paragonix Technologies: COMPANY SNAPSHOT TABLE 39. Paragonix Technologies: OPERATING SEGMENTS TABLE 40. XVIVO Perfusion AB: COMPANY SNAPSHOT TABLE 41. XVIVO Perfusion AB: OPERATING SEGMENTS TABLE 42. Dr. Franz Köhler Chemie GmbH: COMPANY SNAPSHOT TABLE 43. Dr. Franz Köhler Chemie GmbH: OPERATING SEGMENTS TABLE 44. Essential Pharmaceuticals, LLC: COMPANY SNAPSHOT TABLE 45. Essential Pharmaceuticals, LLC: OPERATING SEGMENTS TABLE 46. TransMedics: COMPANY SNAPSHOT TABLE 47. TransMedics: OPERATING SEGMENTS TABLE 48. OrganOx Limited: COMPANY SNAPSHOT TABLE 49. OrganOx Limited: OPERATING SEGMENTS TABLE 50. 21st Century Medicine: COMPANY SNAPSHOT TABLE 51. 21st Century Medicine: OPERATING SEGMENTS TABLE 52. Shanghai Genext Medical Technology: COMPANY SNAPSHOT TABLE 53. Shanghai Genext Medical Technology: OPERATING SEGMENTS TABLE 54. Bridge to Life Limited: COMPANY SNAPSHOT TABLE 55. Bridge to Life Limited: OPERATING SEGMENTS TABLE 56. Waters Medical Systems: COMPANY SNAPSHOT TABLE 57. Waters Medical Systems: OPERATING SEGMENTS TABLE 58. Preservation Solutions: COMPANY SNAPSHOT TABLE 59. Preservation Solutions: OPERATING SEGMENTS TABLE 60. Carnamedica: COMPANY SNAPSHOT TABLE 61. Carnamedica: OPERATING SEGMENTS TABLE 62. Transplant Biomedicals: COMPANY SNAPSHOT TABLE 63. Transplant Biomedicals: OPERATING SEGMENTS TABLE 64. Institut Georges Lopez: COMPANY SNAPSHOT TABLE 65. Institut Georges Lopez: OPERATING SEGMENTS TABLE 66. Global Transplant Solutions: COMPANY SNAPSHOT TABLE 67. Global Transplant Solutions: OPERATING SEGMENTS TABLE 68. Avionord: COMPANY SNAPSHOT TABLE 69. Avionord: OPERATING SEGMENTS TABLE 70. Organ Preservation Solutions: COMPANY SNAPSHOT TABLE 71. Organ Preservation Solutions: OPERATING SEGMENTS TABLE 72. EBERS: COMPANY SNAPSHOT TABLE 73. EBERS: OPERATING SEGMENTS TABLE 74. SALF: COMPANY SNAPSHOT TABLE 75. SALF: OPERATING SEGMENTS TABLE 76. Biochefa: COMPANY SNAPSHOT TABLE 77. Biochefa: OPERATING SEGMENTS TABLE 78. Vascular Perfusion Solutions: COMPANY SNAPSHOT TABLE 79. Vascular Perfusion Solutions: OPERATING SEGMENTS TABLE 80. TX Innovations: COMPANY SNAPSHOT TABLE 81. TX Innovations: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Solution-Based Estimation Figure 6 Top 22 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Organ Preservation Market, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Organ Preservation Market, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Organ, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By End-user, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Solution, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By Preservation Technique, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 University of Wisconsin to Witness Higher CAGR in Market for Solution Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period. Figure 18 Kidneys to Witness Higher CAGR in the Market for Organ Segment during Forecast Period. Figure 19 Static Cold Storage to Witness Higher CAGR in Market for Preservation Technique Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview